References
- Anabousi, S., Bakowsky, U., et al. (2006). In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer. Eur J Pharm Sci 29:367–374.
- Anabousi, S., Kleemann, E., et al. (2006). Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant. J Nanosci Nanotechnol 6:3010–3016.
- Bakowsky, H., Richter, T., et al. (2008). Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochim Biophys Acta 1778:242–249.
- Deshpande, D., Blanchard, J., et al. (2002). Aerosolization of lipoplexes using AERx Pulmonary Delivery System. AAPS PharmSci 4:E13.
- Elhissi, A.M., Karnam, K.K., et al. (2006). Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 58:887–894.
- Elhissi, A.M., Faizi, M., et al. (2007). Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int J Pharm 334:62–70.
- Gaspar, M.M., Bakowsky, U., Ehrhardt, C. (2008). Inhaled liposomes—current strategies and future challenges. J Biomed Nanotechnol 4:245–257.
- Gaspar, M.M., Perez-Soler, R., Cruz, M.E. (1996). Biological characterization of L-asparaginase liposomal formulations. Cancer Chemother Pharmacol 38:373–377.
- Geller, D.E. (2002). New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Respir Care 47:1392–1404.
- Ghazanfari, T., Elhissi, A.M., et al. (2007). The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm 339:103–111.
- Kleemann, E., Schmehl, T., et al. (2007). Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. Pharm Res 24:277–287.
- Knight, V., Gilbert, B. (1988). Antiviral therapy with small particle aerosols. Eur J Clin Microbiol Infect Dis 7:721–731.
- Lammers, T., Hennink, W.E., Storm, G. (2008). Tumour-targeted nanomedicines: principles and practice. Br J Cancer 99:392–397.
- Li, Z., Zhang, Y., et al. (2008). Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. J Aerosol Med Pulm Drug Deliv 21:245–254.
- Niven, R.W., Schreier, H. (1990). Nebulization of liposomes. I. Effects of lipid composition. Pharm Res 7:1127–1133.
- Niven, R.W., Speer, M., Schreier, H. (1991). Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharm Res 8:217–221.
- Niven, R.W., Carvajal, T.M., Schreier, H. (1992). Nebulization of liposomes. III. The effects of operating conditions and local environment. Pharm Res 9:515–520.
- Selting, K., Waldrep, J.C., et al. (2008). Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter. J Aerosol Med Pulm Drug Deliv 21:255–268.
- Stewart, J.C. (1980). Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14.
- Torchilin, V.P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160.
- Tronde, A., Baran, G., et al. (2002). Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med 15:283–296.
- Watts, A.B., McConville, J.T., Williams, R.O., 3rd. (2008). Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm 34:913–922.
- Waldrep, J.C., Keyhani, K., et al. (1994). Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 105:106–110.
- Waldrep, J.C., Dhand, R. (2008). Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv 5:114–119.
- Zaru, M., Mourtas, S., et al. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67:655–666.